The company is managed by experts who have a broad experience in the life science industry. The experts are directed by:
Rene van der Linden, Pharm.D Chief Executive Officer
Mr Van der Linden obtained a MSc in pharmacy and his Pharm.D at the University of Utrecht, the Netherlands. Further he holds a bachelor’s degree in Business Economics. He has 20 years of experience in bringing projects forward due to several commercial, strategic and executional positions at SmithKline Beecham, Organon France, Organon Head quarters, Pantarhei Bioscience. Rene is the founder of MEDIR.
Prof. Frans Merkus, Pharm.D, Ph.D Chief Scientific Advisor
Mr. Merkus, emeritus professor Biopharmaceutics at the Dutch Universities of Amsterdam and of Leiden, is a key opinion leader in intranasal drug delivery. He is the (co-) author of more than 200 international scientific publications and several reference books and he was supervisor of more than a dozen Ph D students. Beside his scientific career, he has extensive experience in running and guiding businesses.
Ed van der Vorst, MBA, MSc. Chief Financial Officer
Mr. van der Vorst is responsible for managing the financial actions of the company. He has a broad experience in the financial business, obtained in multiple positions he fulfilled over the past 45 years. Ed gained experience in multiple business areas in national and international settings.
Peter Mouthaan, BBA, CEDEP Chief Commercial Officer
Mr. Mouthaan is responsible for the commercial development of the company. He is passionate about bringing game changers to the market. He has a background in project- marketing- and executive management. He is an experienced entrepreneur and has attributed to building many company’s over the past 20 years.
Further the team is assisted by external experts, e.g. Dr. F. van Och (Preclinical at 3D-PXC), Dr. R van der Geest (Clinical at 3D-PXC), Dr. B Tuk (business development at TCIM) and anaesthesiologists, neurologists and regulatory experts.